Q9GLV6 AF NFT

Antiviral innate immune response receptor RIG-I

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeib7idwz7vrwg7qac3ltxsdbzolzgwifmfazkkjoquy2uqtr3kdrsq/metadata.json
IPFS of structure file: 
bafybeidsvoeub7uort2y5blyo5oewz4h67omyuxer42a4eu33s2pd3a6ea/AF-Q9GLV6-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x04de7B7fF3D4429895E28Ed9F5d790AD0196Da63
First NFT owner address (bech32): 
genesis1qn08klln63pf390z3mvlt4us45qedknra5gy4d
Current NFT ID #93557 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
93557
Accession (UniProt):
Q9GLV6
Name::
Antiviral innate immune response receptor RIG-I
Experimental Method:
Predicted structure
Sequence source:
SUS SCROFA

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q9GLV6 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q9GLV6|DDX58_PIG Antiviral innate immune response receptor RIG-I OS=Sus scrofa OX=9823 GN=DDX58 PE=2 SV=1 MTAEQRRNLHAFGDYVRKTLDPTFILSYMAPWFRDDEVQHIQAEKNNKGPTEAASLFLQFLLELQEEGWFRGFLDALNQAGYCGLCEAIESWDFQKIEKLEEYRSLLRRLQPEFKTTINPKDILPEIAECLISQECEEILQICSSKGLMAGAEKMVECLLRSDKENWPKTLKLALEKEESRFSELWMVDKGAEDVKMKDLEDDEMKTCDVQIFYKEEPENQNLSQNSCSSSAPHTYSPLKPRKYQLELALPAQNGKNTIICAPTGCGKTFVSLLICEHHLKKFPRGRKGKVVFFAIQLPVYEQQKSVFSKHFERLGYKVAGISGATSDTVCVEQIVENSDIIILTPQILVNCLTNGTIPSLSVFTLMIFDECHNTSKQHPYNVIMFSYLDRKLGGSSDSLPQVIGLTASVGVGDAKNKAEATEYICKLCASLDTSVIATVRDNLEELEEVVYKPQKFFRKVELRTTDRFKCIISQLMMEIESLAKSIFEELGTITLGGLFQIQNSNFGTQKYEQWIVKVQKECAVFQMPDKDKESRICKALFSYMSHLRIYNDALIINEHARMKDALDYLKDFFRNIRAAGFDEIEQDLTQRFEEKLQELESISIDPSNENPKLRDLCFILQEEYHLNPETRTILFVKTRALVDALKKWIKENPKLSFLKPSILTGRGKTNQNIGMTLPAQKCVLDTFRTDKDNKILITTSVADEGIDIAQCNLVILYEYVGNVIKMIQTRGRGRARGSKCFLLTANADLIDKEKMNMYKEEMMNGAILILQTWDEAVFKEKIHQIQIREKIIRDNQGKPEPVPDKKTKKLLCKKCKAFACYTADIRMVEKCHFTVVGDAFRERFVSKLHPKPKSFGNIEKRAKIYCARPDCSHDWGIYVRYKAFEMPFIKIESFVVEDIATGVQTVHAKWKDFNFEKLSFDAAEMAGGAQDLGLQGMGN